Bruker Reports First Quarter Financial Results
Q1 2022 revenue growth of 7.3% year-over-year (yoy); organic revenue growth of 10.5% Q1 2022 GAAP EPS $0.41; non-GAAP EPS $0.49, up 11.4% yoy Raising fiscal year 2022 organic revenue outlook on strong demand for the Company’s high-performance life science tools, scientific instruments and diagnostic solutions BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced... Read more